Evidence map›Paper›PMID 41050616›Full record

ArticleDermatology research and practice2025

Patients With Skin Cancer Prefer to Participate in Procedure Cost Discussions: A Cross-Sectional Survey.

Ritika Bhandari, Laura Rezac, Ross L Pearlman, Vinayak K Nahar, William H Black

Abstract read
In one paragraph

Article in Dermatology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ritika BhandariDepartment of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Laura RezacDepartment of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Ross L PearlmanDepartment of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA.ORCID https://orcid.org/0000-0001-8471-2360
Vinayak K NaharDepartment of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA.ORCID https://orcid.org/0000-0002-6771-1662
William H BlackDepartment of Dermatology, University of Mississippi Medical Center, Jackson, Mississippi, USA.ORCID https://orcid.org/0000-0001-9265-6629

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For a given skin cancer, a number of treatment options are often available. The decision of which method to use is usually made by the treating physician. Despite significant changes to the healthcare system of the United States over the past 10 years, healthcare costs continue to rise. These costs often affect patients in the form of higher deductibles, copays, and insurance premiums. The goal of this study was to determine patient attitudes regarding discussion of cost of skin cancer removal procedures and repairs. A 12-question survey was administered to 100 patients presenting for treatment of a skin cancer at an academic center. The first six questions addressed the importance the patient placed on treatment cost and related discussions, and the final six questions addressed repair cost. Greater than two-thirds of respondents felt that cost of both treatment (76%) and repair (67%) is somewhat or very important. Most patients reported that the cost of skin cancer treatment (56%) and repair (54%) should be considered by their surgeon. Furthermore, a majority of participants felt that cost differences should be discussed prior to treatment (67%) or repair (67%). Most respondents believed that cost discussion prior to treatment (64%) and repair (67%) would not affect their level of procedural anxiety. In conclusion, patients value cost discussions for treatment and repair of skin cancer. Surgeons should consider discussing these issues with patients in the appropriate clinical setting.

Indexed as

costMohs micrographic surgerypatient discussionskin cancer

Identifiers

PMID41050616
PMCPMC12490919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.